CAS: 1047644-62-1 - Afuresertib
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GSK-2110183C REF: IN-DA008TDACAS: 1047644-62-1 | 99% | To inquire | Tue 10 Dec 24 |
 | Afuresertib REF: TM-T1911CAS: 1047644-62-1 | 97.51% - 99.17% | 39.00 €~1,013.00 € | Tue 17 Dec 24 |
 | Afuresertib REF: 3D-BA166066CAS: 1047644-62-1 | Min. 95% | To inquire | Tue 21 Jan 25 |
GSK-2110183C
CAS:1047644-62-1
Formula:
C18H17Cl2FN4OS
Purity:
99%
Color and Shape:
Solid
Molecular weight:
427.3232
Ref: IN-DA008TDA
| 5mg | 192.00 € | ||
| 25mg | 162.00 € | ||
| 50mg | 284.00 € | ||
| 100mg | 612.00 € | ||
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Afuresertib
CAS:1047644-62-1
Afuresertib (GSK2110183) is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase …
Formula:
C18H17Cl2FN4OS
Purity:
97.51% - 99.17%
Color and Shape:
Solid
Molecular weight:
427.32
- Inhibitors
- PKC
- ROCK
- Stem Cell and Derivatives
- See more categories
- Stem Cells
- Cytoskeletal Signaling
Ref: TM-T1911
| 1mg | 39.00 € | ||
| 2mg | 50.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 95.00 € | ||
| 25mg | 171.00 € | ||
| 50mg | 268.00 € | ||
| 100mg | 467.00 € | ||
| 500mg | 1,013.00 € | ||
| 1mL*10mM (DMSO) | 79.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Afuresertib
CAS:1047644-62-1
Inhibitor of pan-AKT
Formula:
C18H17Cl2FN4OS
Purity:
Min. 95%
Molecular weight:
427.32 g/mol
Ref: 3D-BA166066
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
